![]() |
Name |
Phytane
|
Molecular Formula | C20H42 | |
IUPAC Name* |
2,6,10,14-tetramethylhexadecane
|
|
SMILES |
CCC(C)CCCC(C)CCCC(C)CCCC(C)C
|
|
InChI |
InChI=1S/C20H42/c1-7-18(4)12-9-14-20(6)16-10-15-19(5)13-8-11-17(2)3/h17-20H,7-16H2,1-6H3
|
|
InChIKey |
GGYKPYDKXLHNTI-UHFFFAOYSA-N
|
|
Synonyms |
Phytane; 2,6,10,14-TETRAMETHYLHEXADECANE; 638-36-8; Phytan; 2,6,10,14-tetramethyl-hexadecane; Hexadecane, 2,6,10,14-tetramethyl-; 27UZX1Q8TR; 2,6,10,14-Tetramethylhexdecane; Phytane 10 microg/mL in Isooctane; EINECS 211-332-2; Hexadecane,2,6,10,14-tetramethyl-; UNII-27UZX1Q8TR; Phytane, analytical standard; TETRAHYDRONEOPHYTADIENE; CHEBI:48937; HSDB 8346; DTXSID70862339; LMPR0104010019; FT-0739716; Q171701
|
|
CAS | 638-36-8 | |
PubChem CID | 12523 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 282.5 | ALogp: | 9.9 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 13 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 20 | QED Weighted: | 0.325 |
Caco-2 Permeability: | -4.566 | MDCK Permeability: | 0.00000631 |
Pgp-inhibitor: | 0.037 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.205 |
30% Bioavailability (F30%): | 0.882 |
Blood-Brain-Barrier Penetration (BBB): | 0.406 | Plasma Protein Binding (PPB): | 98.20% |
Volume Distribution (VD): | 2.853 | Fu: | 1.93% |
CYP1A2-inhibitor: | 0.207 | CYP1A2-substrate: | 0.182 |
CYP2C19-inhibitor: | 0.279 | CYP2C19-substrate: | 0.528 |
CYP2C9-inhibitor: | 0.296 | CYP2C9-substrate: | 0.926 |
CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.024 |
CYP3A4-inhibitor: | 0.171 | CYP3A4-substrate: | 0.117 |
Clearance (CL): | 6.623 | Half-life (T1/2): | 0.026 |
hERG Blockers: | 0.039 | Human Hepatotoxicity (H-HT): | 0.019 |
Drug-inuced Liver Injury (DILI): | 0.174 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.013 | Maximum Recommended Daily Dose: | 0.024 |
Skin Sensitization: | 0.944 | Carcinogencity: | 0.032 |
Eye Corrosion: | 0.992 | Eye Irritation: | 0.933 |
Respiratory Toxicity: | 0.134 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000627 | ![]() |
0.914 | D00FSV | ![]() |
0.436 | ||
ENC000766 | ![]() |
0.754 | D05QNO | ![]() |
0.229 | ||
ENC000538 | ![]() |
0.746 | D0X4FM | ![]() |
0.217 | ||
ENC000536 | ![]() |
0.741 | D03LGY | ![]() |
0.216 | ||
ENC000537 | ![]() |
0.702 | D0D9NY | ![]() |
0.206 | ||
ENC000902 | ![]() |
0.644 | D0ZI4H | ![]() |
0.198 | ||
ENC001722 | ![]() |
0.632 | D0T9TJ | ![]() |
0.197 | ||
ENC000806 | ![]() |
0.621 | D0N3NO | ![]() |
0.185 | ||
ENC000354 | ![]() |
0.612 | D0G2KD | ![]() |
0.184 | ||
ENC000622 | ![]() |
0.593 | D0P1RL | ![]() |
0.179 |